145 related articles for article (PubMed ID: 6457556)
1. Cefoperazone treatment of experimental endocarditis.
Snepar RA; Carrizosa J; Kobasa WD; Kaye D
Antimicrob Agents Chemother; 1981 May; 19(5):773-6. PubMed ID: 6457556
[TBL] [Abstract][Full Text] [Related]
2. Enoxacin compared with cefoperazone for the treatment of experimental Enterobacter aerogenes endocarditis.
Boscia JA; Kobasa WD; Kaye D
Antimicrob Agents Chemother; 1985 May; 27(5):708-11. PubMed ID: 3860186
[TBL] [Abstract][Full Text] [Related]
3. Treatment of experimental Staphylococcus aureus endocarditis: comparison of cephalothin, cefazolin, and methicillin.
Carrizosa J; Santoro J; Kaye D
Antimicrob Agents Chemother; 1978 Jan; 13(1):74-7. PubMed ID: 626493
[TBL] [Abstract][Full Text] [Related]
4. Comparison of ceforanide, cefazolin, methicillin, and nafcillin in Staphylococcus aureus endocarditis therapy in rabbits.
Carrizosa J; Kobasa WD; Kaye D
Antimicrob Agents Chemother; 1980 Oct; 18(4):562-5. PubMed ID: 7447418
[TBL] [Abstract][Full Text] [Related]
5. Aztreonam, cefoperazone, and gentamicin in the treatment of experimental Enterobacter aerogenes endocarditis in rabbits.
Kobasa WD; Kaye D
Antimicrob Agents Chemother; 1983 Sep; 24(3):321-4. PubMed ID: 6685454
[TBL] [Abstract][Full Text] [Related]
6. Comparison of difloxacin, enoxacin, and cefoperazone for treatment of experimental Enterobacter aerogenes endocarditis.
Boscia JA; Kobasa WD; Kaye D
Antimicrob Agents Chemother; 1987 Mar; 31(3):458-60. PubMed ID: 3472489
[TBL] [Abstract][Full Text] [Related]
7. Comparative evaluation of cefamandole and cephalothin in the treatment of experimental Staphylococcus aureus osteomyelitis in rabbits.
Mader JT; Wilson KJ
J Bone Joint Surg Am; 1983 Apr; 65(4):507-13. PubMed ID: 6833327
[No Abstract] [Full Text] [Related]
8. Effectiveness of nafcillin, methicillin, and cephalothin in experimental Staphylococcus aureus endocarditis.
Carrizosa J; Kobasa WD; Kaye D
Antimicrob Agents Chemother; 1979 May; 15(5):735-7. PubMed ID: 525991
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic therapy of experimental Staphylococcus epidermidis endocarditis.
Vazquez GJ; Archer GL
Antimicrob Agents Chemother; 1980 Feb; 17(2):280-5. PubMed ID: 7387148
[TBL] [Abstract][Full Text] [Related]
10. Cefamandole-aminoglycoside therapy of experimental enterococcal endocarditis.
Weinstein AJ; Fieker D; Hall G
J Antimicrob Chemother; 1983 Jan; 11(1):61-7. PubMed ID: 6826487
[TBL] [Abstract][Full Text] [Related]
11. Correlation of in vitro activities of cephalothin and ceftazidime with their efficacies in the treatment of Staphylococcus aureus endocarditis in rabbits.
Baker RL; Fass RJ
Antimicrob Agents Chemother; 1984 Aug; 26(2):231-4. PubMed ID: 6385840
[TBL] [Abstract][Full Text] [Related]
12. Mezlocillin and ticarcillin alone and combined with gentamicin in the treatment of experimental Enterobacter aerogenes endocarditis.
Levison ME; Kobasa WD
Antimicrob Agents Chemother; 1984 Jun; 25(6):683-6. PubMed ID: 6742813
[TBL] [Abstract][Full Text] [Related]
13. Comparison of BL-S786 with cephalothin, cefamandole and cefoxitin in vitro and in treatment of experimental infections in mice.
Goering RV; Sanders CC; Sanders W
J Antibiot (Tokyo); 1978 Apr; 31(4):363-72. PubMed ID: 306989
[TBL] [Abstract][Full Text] [Related]
14. Cephalosporin-aminoglycoside synergism in experimental enterococcal endocarditis.
Weinstein AJ; Lentnek AL
Antimicrob Agents Chemother; 1976 Jun; 9(6):983-7. PubMed ID: 938028
[TBL] [Abstract][Full Text] [Related]
15. The impact of penicillinase on cefamandole treatment and prophylaxis of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
Que YA; Entenza JM; Francioli P; Moreillon P
J Infect Dis; 1998 Jan; 177(1):146-54. PubMed ID: 9419181
[TBL] [Abstract][Full Text] [Related]
16. Importance of beta-lactamase inactivation in treatment of experimental endocarditis caused by Staphylococcus aureus.
Goldman PL; Petersdorf RG
J Infect Dis; 1980 Mar; 141(3):331-7. PubMed ID: 6965978
[TBL] [Abstract][Full Text] [Related]
17. Comparison of cefamandole, cephalothin, ampicillin, and chloramphenicol in experimental Escherichia coli meningitis.
Beam TR; Allen JC
Antimicrob Agents Chemother; 1980 Jan; 17(1):37-42. PubMed ID: 6986115
[TBL] [Abstract][Full Text] [Related]
18. Treatment evaluation of experimental staphylococcal infections: comparison of beta-lactam, lipopeptide, and glycopeptide antimicrobial therapy.
Fasching CE; Peterson LR; Moody JA; Sinn LM; Gerding DN
J Lab Clin Med; 1990 Nov; 116(5):697-706. PubMed ID: 1967132
[TBL] [Abstract][Full Text] [Related]
19. Quinupristin-dalfopristin combined with beta-lactams for treatment of experimental endocarditis due to Staphylococcus aureus constitutively resistant to macrolide-lincosamide-streptogramin B antibiotics.
Vouillamoz J; Entenza JM; Féger C; Glauser MP; Moreillon P
Antimicrob Agents Chemother; 2000 Jul; 44(7):1789-95. PubMed ID: 10858332
[TBL] [Abstract][Full Text] [Related]
20. Synergistic enhancement of in vitro antimicrobial activity of imipenem and cefazolin, cephalothin, cefotiam, cefamandole or cefoperazone in combination against methicillin-sensitive and -resistant Staphylococcus aureus.
Uete T; Matsuo K
Jpn J Antibiot; 1995 Mar; 48(3):402-8. PubMed ID: 7752453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
